Market and company headlines
InFoods® IBS Commercial Progress: Medicare-related test orders increased 120% in September 2026 compared to August, with growing physician participation and repeat ordering activityInFoods® IBS update: 100% of all initial valid Medicare claims processed as of October 15, 2026 have been paid at the full CMS payment rate of $300Engaged B. Riley Securities, Inc. to support the Board's ongoing evaluation of potential strategic opportunities, including partnerships and business combinationsTotal oper
Yahoo·08:19·11 Days AgoBMRA▼−0.6%
Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.37) per share. The company reported $1.265 million in sales this quarter. This is a 8.33 percent decrease over sales of $1.380 million the same period last year.
Benzinga·14:17BMRA▼−0.6%
BIOMERICA, INC. $250,000,000 Common StockPreferred StockDebt SecuritiesWarrants We may offer and sell the securities identified above from time to time in one or more offerings, in amounts, at prices and on terms
Benzinga·11:01BMRA▼−0.6%
BIOMERICA, INC. 1,403,705 Shares of Common Stock This prospectus relates to the proposed resale or other disposition by the selling stockholders identified in this prospectus of up to 1,403,705 shares of our common
Benzinga·13:04BMRA▼−0.6%
